Cargando…
Elevated Prevalence of Abnormal Glucose Metabolism and Other Endocrine Disorders in Patients with β-Thalassemia Major: A Meta-Analysis
BACKGROUND: Endocrinopathies are common in patients with β-thalassemia major despite parenteral iron chelation therapy with deferoxamine. Prevalence of abnormal glucose metabolism in previous studies was controversial. The aim of this study was to discuss the prevalence of abnormal glucose metabolis...
Autores principales: | He, Li-Na, Chen, Wei, Yang, Yi, Xie, Ying-Jun, Xiong, Ze-Yu, Chen, Di-Yu, Lu, Dian, Liu, Neng-Qing, Yang, Ying-Hong, Sun, Xiao-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500678/ https://www.ncbi.nlm.nih.gov/pubmed/31119181 http://dx.doi.org/10.1155/2019/6573497 |
Ejemplares similares
-
Growth and Endocrine Function in Tunisian Thalassemia Major Patients
por: Dhouib, Naouel Guirat, et al.
Publicado: (2018) -
New Entity—Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement
por: Carsote, Mara, et al.
Publicado: (2022) -
Prevalence of abnormal glucose homeostasis in Chinese patients with non-transfusion-dependent thalassemia
por: Luo, Yunchen, et al.
Publicado: (2019) -
Detection of endocrine disorders in young children with multi-transfused thalassemia major
por: Mahmoud, Ramadan A., et al.
Publicado: (2021) -
Detection of glycemic abnormalities in adolescents with beta thalassemia using continuous glucose monitoring and oral glucose tolerance in adolescents and young adults with β-thalassemia major: Pilot study
por: Soliman, Ashraf T., et al.
Publicado: (2013)